POH would have to improve dramatically in its ability to get products to market - past evidence does not suggest it does that well.
Where is Terumo? Surely they can see POH has lost some of its power - if POH had really promising stuff to offer, why has Terumo not pounced? I think that might be a worrying sign. Lots of chatter about the merits of POH's products but maybe the real item of interest is whether POH has the products plus ability to convince a commercial partner to have confidence in those products. At this stage the real game is in the board room and not the science lab.
Deafening silence from all angles really which is disconcerting to all I suspect
Having said that, I don't believe POH is an empty shell and am considering buying back in for a small parcel. It will either buck up dramatically (guess that won't be that big a deal with a start price of.04cents) or it will close it doors by the end of the year. I'm betting we will see POH in 2020 and it will be stronger. However, the coin has not been flipped yet. C'mon POH.
- Forums
- ASX - By Stock
- Ann: Updated Presentation to Support CEO Partnering Meetings
POH would have to improve dramatically in its ability to get...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online